Cargando…
Adenosine A(2B) Receptors: An Optional Target for the Management of Irritable Bowel Syndrome with Diarrhea?
Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder, with the characteristic symptoms of chronic abdominal pain and altered bowel habits (diarrhea, constipation, or both). IBS is a highly prevalent condition, which negatively affects quality of life and is a significant burden o...
Autores principales: | Asano, Teita, Takenaga, Mitsuko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704121/ https://www.ncbi.nlm.nih.gov/pubmed/29099770 http://dx.doi.org/10.3390/jcm6110104 |
Ejemplares similares
-
Aminophylline suppresses stress-induced visceral hypersensitivity and defecation in irritable bowel syndrome
por: Asano, Teita, et al.
Publicado: (2017) -
A(2B) adenosine receptor inhibition by the dihydropyridine calcium channel blocker nifedipine involves colonic fluid secretion
por: Asano, Teita, et al.
Publicado: (2020) -
Targeted therapies for diarrhea-predominant irritable bowel syndrome
por: Olden, Kevin W
Publicado: (2012) -
Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea
por: Colomier, Esther, et al.
Publicado: (2021) -
Diarrhea-Predominant Irritable Bowel Syndrome: Medical Management Update
por: Andrews, Christopher N, et al.
Publicado: (2019)